Participant Retention in Follow-Up Studies of Acute Respiratory Failure Survivors.

Critical Illness Follow-Up Studies Humans Respiratory Distress Syndrome / therapy Respiratory Insufficiency / etiology Survivors
acute respiratory failure cohort follow-up studies meta-analysis participant retention systematic review

Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 3 4 2020
medline: 23 2 2021
entrez: 3 4 2020
Statut: ppublish

Résumé

With an increasing number of follow-up studies of acute respiratory failure survivors, there is need for a better understanding of participant retention and its reporting in this field of research. Hence, our objective was to synthesize participant retention data and associated reporting for this field. Two screeners independently searched for acute respiratory failure survivorship studies within a published scoping review to evaluate subject outcomes after hospital discharge in critical illness survivors. There were 21 acute respiratory failure studies ( Participant retention was generally high but varied greatly across individual studies and time points, with 24% of studies reporting inadequate data to calculate retention rate. High participant retention is possible, but resources for optimizing retention may help studies retain participants. Improved reporting guidelines with greater adherence would be beneficial.

Sections du résumé

BACKGROUND BACKGROUND
With an increasing number of follow-up studies of acute respiratory failure survivors, there is need for a better understanding of participant retention and its reporting in this field of research. Hence, our objective was to synthesize participant retention data and associated reporting for this field.
METHODS METHODS
Two screeners independently searched for acute respiratory failure survivorship studies within a published scoping review to evaluate subject outcomes after hospital discharge in critical illness survivors.
RESULTS RESULTS
There were 21 acute respiratory failure studies (
CONCLUSIONS CONCLUSIONS
Participant retention was generally high but varied greatly across individual studies and time points, with 24% of studies reporting inadequate data to calculate retention rate. High participant retention is possible, but resources for optimizing retention may help studies retain participants. Improved reporting guidelines with greater adherence would be beneficial.

Identifiants

DOI: 10.4187/respcare.07461 PMID: 32234765 PMC: PMC7906609
pubmed: 32234765
pii: respcare.07461
doi: 10.4187/respcare.07461
pmc: PMC7906609
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1382-1391

Subventions

Organisme : NHLBI NIH HHS
ID : R24 HL111895
Pays : United States

Informations de copyright

Copyright © 2020 by Daedalus Enterprises.

Références

Chest. 2013 Apr;143(4):920-926
pubmed: 23187463
J Clin Epidemiol. 2007 Aug;60(8):757-65
pubmed: 17606170
Arch Dis Child. 2008 Jun;93(6):458-61
pubmed: 18495909
Crit Care Med. 2008 Oct;36(10):2726-33
pubmed: 18766087
Intensive Care Med. 2012 Feb;38(2):221-9
pubmed: 22187085
N Engl J Med. 2011 Apr 7;364(14):1293-304
pubmed: 21470008
Chest. 2011 Jun;139(6):1340-1346
pubmed: 21330382
Enferm Intensiva. 2003 Jul-Sep;14(3):88-95
pubmed: 14499100
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Crit Care. 2010;14(2):R60
pubmed: 20384998
Sleep Med. 2012 Sep;13(8):1106-9
pubmed: 22763017
JAMA. 2001 Apr 18;285(15):1987-91
pubmed: 11308435
Intensive Care Med. 2009 May;35(5):796-809
pubmed: 19165464
Psychosomatics. 2006 Sep-Oct;47(5):399-407
pubmed: 16959928
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Crit Care Med. 2014 Apr;42(4):849-59
pubmed: 24247473
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Am J Med. 2000 Dec 1;109(8):614-20
pubmed: 11099680
Chest. 2009 Mar;135(3):678-687
pubmed: 19265087
Am J Respir Crit Care Med. 2001 May;163(6):1389-94
pubmed: 11371406
Crit Care Med. 2016 Jul;44(7):1267-77
pubmed: 26992067
Crit Care Resusc. 2006 Dec;8(4):302-8
pubmed: 17227266
Am J Respir Crit Care Med. 2003 Mar 1;167(5):690-4
pubmed: 12493646
Am J Respir Crit Care Med. 2010 May 15;181(10):1121-7
pubmed: 20224063
Chest. 2004 Dec;126(6):1897-904
pubmed: 15596690
Crit Care Med. 2013 Feb;41(2):445-56
pubmed: 23263616
Crit Care Med. 2015 May;43(5):1121-9
pubmed: 25654178
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
BMC Med Res Methodol. 2014 Dec 19;14:135
pubmed: 25524443
Am J Respir Crit Care Med. 2013 Sep 1;188(5):567-76
pubmed: 23805899
Crit Care Med. 2006 Dec;34(12):2883-90
pubmed: 17075373
Am J Respir Crit Care Med. 1994 Jul;150(1):90-4
pubmed: 8025779
J Clin Epidemiol. 2015 Dec;68(12):1481-7
pubmed: 26186981
Intensive Care Med. 2006 Nov;32(11):1826-31
pubmed: 16957904
Thorax. 2005 May;60(5):401-9
pubmed: 15860716
Brain Inj. 2010;24(12):1478-84
pubmed: 20858026
Chest. 2011 Dec;140(6):1484-1493
pubmed: 21998261
Intensive Care Med. 2006 Nov;32(11):1895-900
pubmed: 16983550
N Engl J Med. 2013 Oct 3;369(14):1306-16
pubmed: 24088092
Gen Hosp Psychiatry. 2010 Mar-Apr;32(2):147-55
pubmed: 20302988
JAMA. 1996 Aug 28;276(8):637-9
pubmed: 8773637
BMC Med Res Methodol. 2017 Feb 20;17(1):30
pubmed: 28219336
Am J Respir Crit Care Med. 1999 Jul;160(1):50-6
pubmed: 10390379
Crit Care Med. 2005 Jul;33(7):1549-56
pubmed: 16003061
Crit Care Med. 2009 May;37(5):1702-7
pubmed: 19357507
Am J Respir Crit Care Med. 2005 Feb 15;171(4):340-7
pubmed: 15542793
Crit Care Med. 2010 Oct;38(10):1947-53
pubmed: 20639743
Am J Phys Med Rehabil. 2006 Jul;85(7):574-81
pubmed: 16788388
Lancet. 2009 Oct 17;374(9698):1351-63
pubmed: 19762075
J Int Neuropsychol Soc. 2004 Nov;10(7):1005-17
pubmed: 15803563
N Engl J Med. 2003 Feb 20;348(8):683-93
pubmed: 12594312
Psychol Med. 2013 Dec;43(12):2657-71
pubmed: 23438256
J Int Neuropsychol Soc. 2007 Jul;13(4):595-605
pubmed: 17521481
Am J Respir Crit Care Med. 2012 Mar 1;185(5):517-24
pubmed: 22161158
Ann Intern Med. 2010 Jun 1;152(11):726-32
pubmed: 20335313
Am J Respir Crit Care Med. 2006 Sep 1;174(5):538-44
pubmed: 16763220
Am J Respir Crit Care Med. 2012 Jun 15;185(12):1307-15
pubmed: 22492988
BMJ. 2013 Mar 19;346:f1532
pubmed: 23512759

Auteurs

Krishidhar Nunna (K)

Department of Critical Care Medicine, Baylor College of Medicine, Houston, Texas.

Awsse Al-Ani (A)

MedStar Union Memorial Hospital, Baltimore, Maryland.

Roozbeh Nikooie (R)

Department of Internal Medicine, Yale New Haven Hospital, New Haven, Connecticut.

Lisa Aronson Friedman (LA)

Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore, Maryland.
Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Vaishnavi Raman (V)

MedStar Union Memorial Hospital, Baltimore, Maryland.

Zerka Wadood (Z)

Division of Pulmonary, Critical Care & Sleep Medicine, University of Florida, Gainesville, Florida.

Sumana Vasishta (S)

Mandya Institute of Medical Sciences, Rajiv Gandhi University of Health Sciences, Karnataka, India.

Elizabeth Colantuoni (E)

Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore, Maryland.
Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Dale M Needham (DM)

Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore, Maryland.
Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.
Department of Physical Medicine and Rehabilitation, School of Medicine, Johns Hopkins University, Baltimore, Maryland and with the School of Nursing, Johns Hopkins University, Baltimore, Maryland.

Victor D Dinglas (VD)

Outcomes After Critical Illness and Surgery Group, Johns Hopkins University, Baltimore, Maryland. victor.dinglas@jhmi.edu.
Division of Pulmonary and Critical Care Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie grave › Participant Retention in Follow-Up Studies of...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études de suivi › Participant Retention in Follow-Up Studies of...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Participant Retention in Follow-Up Studies of...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Troubles respiratoires › Syndrome de détresse respiratoire de l'adulte › Participant Retention in Follow-Up Studies of...
questionsmedicales.fr › Maladies de l'appareil respiratoire › Troubles respiratoires › Insuffisance respiratoire › Participant Retention in Follow-Up Studies of...
questionsmedicales.fr › Personnes › Survivants › Participant Retention in Follow-Up Studies of...